UTI Healthcare Fund Direct-Growth
NAV
₹338.0673
as on 30 Jul 2025, 11:11 PM
₹0.7257(0.22%)
Last Change
Schemes Managed By
Scheme Information
UTI Healthcare Fund Direct-Growth
as of 30 Jun 2025, 05:30 AM
₹1,098.70 Cr
1.26%
1.09%
Open-End
Growth
Exit load of 1% if redeemed within 30 days.
BSE Healthcare Total Return Index
View
Sectors Holding in this Mutual Fund
Healthcare
98.90%
₹1,086.59 Cr
Others
1.10%
₹12.09 Cr
Healthcare
98.90%
₹1,086.59 Cr
Others
1.10%
₹12.09 Cr
Sun Pharmaceutical Industries Ltd.
10.44%
₹114.70 Cr
Cipla Ltd.
5.52%
₹60.65 Cr
Dr. Reddy's Laboratories Ltd.
4.66%
₹51.20 Cr
Procter & Gamble Health Ltd.
4.34%
₹47.68 Cr
Ajanta Pharma Ltd.
4.09%
₹44.94 Cr
Others
70.95%
₹779.53 Cr
Sun Pharmaceutical Industries Ltd.
10.44%
₹114.70 Cr
Cipla Ltd.
5.52%
₹60.65 Cr
Dr. Reddy's Laboratories Ltd.
4.66%
₹51.20 Cr
Procter & Gamble Health Ltd.
4.34%
₹47.68 Cr
Ajanta Pharma Ltd.
4.09%
₹44.94 Cr
Others
70.95%
₹779.53 Cr
Funds in this Category
This fund's returns: 27.90%
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth
Min. Investment
₹100
30.61
Category Returns
19.61%
30.61%
3Y Returns
30.61 %
SBI Healthcare Opportunities Fund Direct Plan-Growth
Min. Investment
₹500
29.67
Category Returns
19.61%
30.61%
3Y Returns
29.67 %
DSP Healthcare Fund Direct - Growth
Min. Investment
₹100
27.38
Category Returns
19.61%
30.61%
3Y Returns
27.38 %
About UTI Healthcare Fund Direct-Growth
UTI Healthcare Fund Direct-Growth scheme return performance in last 1 year is 17.03%, in last 3 years is 109.52% and 608.44% since scheme launch. The min. SIP amount to invest in this scheme is ₹500.
Scheme Details
AUM: | ₹1,098.70 Cr |
Category: | Equity: Sectoral-Pharma |
Launch Date: | Invalid date |
Fund Type: | Open-End |
AMC Information
UTI Mutual Fund
Address
Investment Performance
₹ 1,00,000
would have given a return of
₹1,10,871
₹1,21,647
₹2,03,338
₹2,09,520
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
Profit (absolute return)
₹1,09,520
109.52%
Investment Returns
Scheme Riskometer
Investors understand that their principal will be at very high risk